Active Ingredient: MOBOCERTINIB SUCCINATE
Proprietary Name: EXKIVITY
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 40MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N215310
Product Number: 001
Approval Date: Sep 15, 2021
Applicant Holder Full Name: TAKEDA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
